JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0467?guestAccessKey=92f3e2d1-bd5c-46de-bd55-7c4bb72dcb11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040722 What The Study Did: Prostate biopsy and prostate cancer…
JAMAONCO_OF:03312022
Visual Abstract: TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 31, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3547?guestAccessKey=8d9bd1e6-f049-42d7-afe3-9c8e25f2daa8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122 Visual Abstract Authors: Robin…
Association of Patient-Reported Outcomes With Nonfatal Self-injury After New Cancer Diagnosis
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0203?guestAccessKey=00e63a17-6219-47bf-8c53-40a8bd9f6638&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122
Association of Changes in Medicaid Dental Benefits With Oral Cavity Cancer Diagnosis
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0149?guestAccessKey=6a711b05-104d-497e-9fc0-b0f83e4f049d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122
JAMAONCO_OF:03242022
Self-reported Transportation Barriers to Health Care Among US Cancer Survivors
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0143?guestAccessKey=5cf125ad-4c75-4c74-8fa2-7e2cc23d7191&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032422
Visual Abstract: Paclitaxel, Cisplatin, Capecitabine vs Cisplatin, Fluorouracil for Nasopharyngeal Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 24, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0122?guestAccessKey=0dbfee8b-21aa-4dba-9124-1cad55464019&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032422 Visual Abstract…
JAMAONCO_OF:03172022
Risk of Colorectal Cancer Associated With Lifetime Excess Weight
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 17, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0064?guestAccessKey=f7acd72a-cef3-4048-b6f5-c79e1a5df966&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031722 What The Study Did: A greater number…
JAMAONCO_OF:03102022
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0001?guestAccessKey=28a28d85-7f85-427c-b826-d89f6a8ecb4c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031022
JAMAONCO_OF:03032022
Factors Associated With Racial Disparity in Use of MRI Among Patients With Prostate Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 3, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.8116?guestAccessKey=de4ed44c-76d6-4a00-8162-6f8f7fc66096&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030322 What The Study Did: This study of…
Visual Abstract: Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 3, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.8171?guestAccessKey=89bc130b-ab40-4ac6-88e6-4f65d4a27e5d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030322 Visual Abstract Authors:…
JAMAONCO_OF:02242022
Visual Abstract: Palliative Radiation for Advanced Central Lung Tumors With Avoidance of the Esophagus
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 24, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7664?guestAccessKey=553a7379-6e75-4459-92c7-2ab0b6d97fea&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022422 Visual Abstract…
Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7656?guestAccessKey=d9c22bbb-19ef-4c43-85f7-afc06c85febc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021722
Visual Abstract: Capecitabine Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 17, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7366?guestAccessKey=1105ab84-3fa2-4968-8fc0-a0a004c7679a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021722 Visual Abstract…
JAMAONCO_OF:02172022
Visual Abstract: Autologous Dendritic Cell Immunotherapy Plus Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 10, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7298?guestAccessKey=917838c5-d533-4d82-982c-5950df33843b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022 Visual Abstract…
Visual Abstract: Effect of Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 10, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7643?guestAccessKey=37d42b48-589a-4d9b-82cc-956b70090d11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022 Visual Abstract Authors:…
Association of HPV Vaccination, Incidence of Squamous Cell Carcinomas of Anus
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7652?guestAccessKey=c9a9b5b2-3c4c-405e-8021-ff8ccc302036&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022
JAMAONCO_OF:02102022
JAMAONC_OF:02032022
JAMAONCO_OF:01272022
Geographic Disparities in Treatment of Curable Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 27, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7337?guestAccessKey=7a16d9be-1ed0-42ab-bdbd-f456a1f31f88&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012722 What The Study Did: The extent to which geographic…
JAMAONCO_OF:01202022
JAMAONCO_OF:01132022
Comparing Lung Cancer Screening Criteria for Racial Disparity in Eligibility
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 13, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6720?guestAccessKey=46113213-0bcc-4a03-a1c3-c4ea5e7383a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011322 What The Study Did: The findings of…
JAMAONCO_ADHOC:01072022
SARS-CoV-2 Antibody Response to 2 or 3 Doses of BioNTech-Pfizer Vaccine in Patients With Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, JANUARY 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7777?guestAccessKey=64f57de0-65f5-4ccc-9c30-3abe123b5e3b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010722 What The Study Did: This study assessed the antibody…
Visual Abstract: Comparing Prophylactic Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 6, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6628?guestAccessKey=83a5b584-1fa5-48e4-82a9-28d957bdab6d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010622 Visual Abstract…
JAMAONCO_OF:01062022
Association of Sitting Time, Physical Activity With Cancer Survival
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 6, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6590?guestAccessKey=8b888a7b-1d4c-4ddc-94cb-2cd1ef14deb9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010622 What The Study Did: Researchers examined the associations of…
JAMAONCO_OF:12302021
Global Burden of Cancer, 2010 to 2019
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6987?guestAccessKey=de848f90-c09a-4361-9e2a-fe2c6562d9a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=123021
JAMAONCO_OF:12232021
Visual Abstract: Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 23, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5981?guestAccessKey=f7d45c3d-a78d-4435-a89c-fb8eb9afa57d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122321 Visual Abstract Authors:…
JAMAONCO_OF:12162021
JAMAONCO_OF:12092021
Diversity Among US Radiation, Medical Oncology Faculty
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 9, 2021 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6011?guestAccessKey=bb9a9220-1bbf-4ab2-96f9-b077e4984ff8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120921 What The Study Did: The results of…
JAMAONCO_OF:12022021
Effectiveness of COVID-19 Vaccination in Patients With Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 2, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5771?guestAccessKey=5fcd8b60-734c-4f79-8c52-139d4f069eac&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120221 What The Study Did: In this study of Veterans…
JAMAONCO_OF:11242021
Association Between Neighborhood Socioeconomic Inequality, Cervical Cancer Rates in New York City
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5779?guestAccessKey=875a08ed-82ac-42d8-befe-cd94de00c5cd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421 What The Study Did: In this population-based, cross-sectional study, researchers…
Eligibility of Black Women Under USPSTF Lung Cancer Screening Guidelines
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5790?guestAccessKey=988b5b64-a314-4333-ab42-05e8abd58fe2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421 What The Study Did: Researchers evaluated lung cancer screening eligibility…
Change in COVID-19 Mortality in Patients With Cancer During Pandemic
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6199?guestAccessKey=34bfddf6-8dcb-4cc5-b112-3792eda89ee4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421 What The Study Did: Evolving outcomes of COVID-19 in patients…
Outcomes of Screening for Prostate Cancer Among Men Who Use Statins
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5672?guestAccessKey=b34f9b8a-3809-4044-9079-510749446219&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421
JAMAONCO_OF:11232021
Assessing Response to Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Patients With Solid Tumors
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6764?guestAccessKey=fa2f67e0-5398-479e-9c84-040b27818f41&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112321
JAMAONCO_OF:11182021
Telemedicine Use by Socioeconomic Status Among Patients With Newly Diagnosed Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 18, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5784?guestAccessKey=1bebfa23-1ea5-41a2-ab62-02ba8f55f0b5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821 What The Study Did: Researchers found that among 16,000…
Visual Abstract: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 18, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5445?guestAccessKey=9e2e2632-3143-4a5a-bff7-c19a1983fea5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821 Visual Abstract Authors:…
T-Cell Responses to SARS-CoV-2 Vaccines in Patients With B-Cell Depletion
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6030?guestAccessKey=d5abc9d4-27a3-4f58-bb04-59ee7ca15a4c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821
JAMAONCO_11112021
Progress Against Cancer Deaths 50 Years After National Cancer Act Passed
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 11, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5668?guestAccessKey=fa22406b-0c85-463b-a38f-8a0bcd08f48f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111121 What The Study Did: This year is the 50th anniversary…
JAMAONCO_OF:11042021
JAMAONCO_OF:10282021
COVID-19 Death, Adverse Outcomes in Patients With, Without Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 28, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5148?guestAccessKey=f51f92f4-9ae3-44f9-a1b1-659a3d763658&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102821 What The Study Did: In this study of more than…
JAMAONCO_OF:10252021
Visual Abstract: Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 5:05 P.M. (ET), MONDAY, OCTOBER 25, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6036?guestAccessKey=fccdc560-4934-481d-954a-55b6eb373e97&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102521 Visual Abstract Authors: Chang-Ok…
JAMAONCO_OF:10212021
JAMAONCO_OF:10142021
Visual Abstract: Fulvestrant-Palbociclib vs. Letrozole-Palbociclib as Initial Therapy for Advanced Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 7, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4301?guestAccessKey=4c8d31e5-75de-4219-ac23-dc4434ce706d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100721 Visual Abstract Authors:…
JAMAONCO_OF:10072021
JAMAONCO_OF:09302021
Visual Abstract: Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 23, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3836?guestAccessKey=a7dff299-41e1-42da-b547-14b4adaf1c37&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092321 Visual Abstract Authors:…
JAMAONCO_OF:09232021
JAMAONCO_OF:09162021
JAMAONCO_OF:09092021
Changes in Life Expectancy After Allogeneic Blood or Marrow Transplantation
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 9, 2021 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3676?guestAccessKey=3f852df3-f991-471c-82a1-43005d1ca1a3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090921 What the Study Did: Researchers examined changes…
JAMAONCO_OF:09022021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4083?guestAccessKey=401c5452-3b52-469f-9933-a9d18759821c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2907?guestAccessKey=3cf1521e-cf5a-47b4-bc5c-dcb87818f64e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221
Visual Abstract: Ensartinib vs Crizotinib for Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 2, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3523?guestAccessKey=7cd645db-d6d0-45a4-9410-6c64a6b47b0c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221 Visual Abstract…
JAMAONCO_OF:08292021
JAMAONCO_OF:08262021
Visual Abstract: Effect of Cisplatin, Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 26, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3441?guestAccessKey=52eb480f-85bb-4d72-a750-c6e4ea579e7a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082621 Visual Abstract Authors:…
Visual Abstract: Effectiveness of Adding Everolimus to First-line Treatment of Advanced Breast Cancer in Premenopausal Women
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 26, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3428?guestAccessKey=6fff4c46-c0eb-49ef-b0f8-67ce316f4a8d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082621 Visual Abstract Authors:…
JAMAONCO_08192021
Targeted COVID-19 Vaccine Outreach to Marginalized Populations
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 19, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3833?guestAccessKey=e97a3e2d-c47b-4e45-8c0f-d7e191421467&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081921 What The Study Did: Researchers at the North Carolina Cancer…
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3585?guestAccessKey=cf61110c-09cd-4a01-9041-e0e1412ada0a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081921
Visual Abstract: Effects of Exercise on Prostate Cancer Under Active Surveillance
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 19, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3067?guestAccessKey=b71e6940-300a-4fae-b55d-470ef7e132ca&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081921 Visual Abstract…
JAMAONCO_OF:08122021
Visual Abstract: Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 12, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3186?guestAccessKey=a1568e25-3f53-4723-affc-0c54defb0aa8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081221 Visual Abstract…
JAMAONCO_OF:08112021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4381?guestAccessKey=e21e391b-70b8-42e8-a852-5a369db2c2f4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081121
Durability of Response to SARS-CoV-2 BioNTech-Pfizer Vaccination in Patients on Active Anticancer Treatment
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 11, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/2783031?guestAccessKey=2e3b178f-9053-43ef-9178-298837b421a7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081121 What The Study Did: Researchers describe the antispike IgG antibody…
JAMAONCO_OF:08052021
Visual Abstract: Chemoradiotherapy With S-1 for Older Patients With Esophageal Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 5, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2705?guestAccessKey=1faeb082-838d-4047-865d-058634208242&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080521 Visual Abstract…
Visual Abstract: Metformin With Chemoradiotherapy Outcomes in Locally Advanced Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 29, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2328?guestAccessKey=1e018809-7b94-4606-9e5b-c6d9b7407f33&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072921 Visual Abstract…
JAMAONCO_OF:07292021
Visual Abstract: Comparing Chemoradiation Plus Metformin vs Chemoradiation for Stage III Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 29, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2318?guestAccessKey=d6c68b4c-6e50-4804-b5e2-69f923758f70&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072921 Visual Abstract…
JAMAONCO_OF:07222021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3127?guestAccessKey=0e0076cb-82fb-4273-ab82-bcf0ecb5431f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221
Prostate Cancer Treatment Among Black, White Patients During Pandemic
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 22, 2021 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2755?guestAccessKey=bd1d5058-6861-4ca9-9126-aec996c6ba22&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221 What The Study Did: This study included…
Visual Abstract: Treatment of High-risk Medulloblastoma in Children
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 22, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2224?guestAccessKey=12dbd65b-1312-4066-ab73-41b4830c1581&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221 Visual Abstract…
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2582?guestAccessKey=8a0dd195-672e-4a08-b3b4-3144408c2b25&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221